Salvovar Logo
Restoring hope,
salvaging lives ribbon
What we do
Learn more about what we do
Hope for High Risk Ovarian Cancer Patients

Check out this video to find out how SalvOvar helps both physicians and patients.

Play video  

SALVOVAR is Restoring Hope, Salvaging Lives

A European multi-disciplinary clinical project meant to improve the management of patients with poor prognostic ovarian cancer after neoadjuvant chemotherapy
More about the project

Clinical Trial

Lyon University Hospital (HCL) will oversee the project and ARCAGY-GINECO will sponsor the clinical trial. Around 100 recruiting centers are spread across six European countries (United Kingdom, France, Italy, Netherlands, Israel, and Czech Republic) through the ENGOT network.

A European Scientific Community Dedicated to Identifying and Helping Ovarian Cancer Patients

Physicians can use the free online calculator of KELIM™, a pragmatic indicator of tumor chemosensitivity.

Compute KELIM™

News & events

Learn about the latest news, events and publications regarding the SalvOvar project
Show more

Frequently Asked Questions

European Commission Logo

This project has received funding by the European Union's HORIZON-MISS-CANCER-2022-01 research program under project number 101104469